235 related articles for article (PubMed ID: 27960039)
1. Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood.
Suzuki-Inoue K; Osada M; Ozaki Y
J Thromb Haemost; 2017 Feb; 15(2):219-229. PubMed ID: 27960039
[TBL] [Abstract][Full Text] [Related]
2. Platelet CLEC-2: Roles Beyond Hemostasis.
Suzuki-Inoue K; Tsukiji N; Shirai T; Osada M; Inoue O; Ozaki Y
Semin Thromb Hemost; 2018 Mar; 44(2):126-134. PubMed ID: 28992650
[TBL] [Abstract][Full Text] [Related]
3. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
Suzuki-Inoue K
Blood; 2019 Nov; 134(22):1912-1918. PubMed ID: 31778548
[TBL] [Abstract][Full Text] [Related]
4. Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation.
Suzuki-Inoue K
J Biochem; 2011 Aug; 150(2):127-32. PubMed ID: 21693546
[TBL] [Abstract][Full Text] [Related]
5. New horizon in platelet function: with special reference to a recently-found molecule, CLEC-2.
Ozaki Y; Tamura S; Suzuki-Inoue K
Thromb J; 2016; 14(Suppl 1):27. PubMed ID: 27766053
[TBL] [Abstract][Full Text] [Related]
6. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
Suzuki-Inoue K
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):175-181. PubMed ID: 31808911
[TBL] [Abstract][Full Text] [Related]
7. [CLEC-2 induced signalling in blood platelets].
Martyanov AA; Kaneva VN; Panteleev MA; Sveshnikova AN
Biomed Khim; 2018 Sep; 64(5):387-396. PubMed ID: 30378555
[TBL] [Abstract][Full Text] [Related]
8. Roles of the CLEC-2-podoplanin interaction in tumor progression.
Suzuki-Inoue K
Platelets; 2018 Jun; ():1-7. PubMed ID: 29863945
[TBL] [Abstract][Full Text] [Related]
9. [A role of the platelet receptor CLEC-2 in lymphangiogenesis and its clinical application].
Osada M; Suzuki-Inoue K; Inoue O; Ozaki Y
Rinsho Byori; 2013 Apr; 61(4):318-27. PubMed ID: 23855188
[TBL] [Abstract][Full Text] [Related]
10. Novel platelet activation receptor CLEC-2: from discovery to prospects.
Suzuki-Inoue K; Inoue O; Ozaki Y
J Thromb Haemost; 2011 Jul; 9 Suppl 1():44-55. PubMed ID: 21781241
[TBL] [Abstract][Full Text] [Related]
11. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells.
Osada M; Inoue O; Ding G; Shirai T; Ichise H; Hirayama K; Takano K; Yatomi Y; Hirashima M; Fujii H; Suzuki-Inoue K; Ozaki Y
J Biol Chem; 2012 Jun; 287(26):22241-52. PubMed ID: 22556408
[TBL] [Abstract][Full Text] [Related]
12. Podoplanin-positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC-2.
Tamura S; Suzuki-Inoue K; Tsukiji N; Shirai T; Sasaki T; Osada M; Satoh K; Ozaki Y
Blood; 2016 Mar; 127(13):1701-10. PubMed ID: 26796360
[TBL] [Abstract][Full Text] [Related]
13. [Identification of the novel platelet activation receptor CLEC-2 and Its pathological and physiological roles].
Suzuki Inoue K; Inoue O; Ozaki Y
Rinsho Byori; 2010 Dec; 58(12):1193-202. PubMed ID: 21348239
[TBL] [Abstract][Full Text] [Related]
14. Human podoplanin-positive monocytes and platelets enhance lymphangiogenesis through the activation of the podoplanin/CLEC-2 axis.
Hur J; Jang JH; Oh IY; Choi JI; Yun JY; Kim J; Choi YE; Ko SB; Kang JA; Kang J; Lee SE; Lee H; Park YB; Kim HS
Mol Ther; 2014 Aug; 22(8):1518-1529. PubMed ID: 24736277
[TBL] [Abstract][Full Text] [Related]
15. Platelet adhesion to podoplanin under flow is mediated by the receptor CLEC-2 and stabilised by Src/Syk-dependent platelet signalling.
Navarro-Núñez L; Pollitt AY; Lowe K; Latif A; Nash GB; Watson SP
Thromb Haemost; 2015 May; 113(5):1109-20. PubMed ID: 25694214
[TBL] [Abstract][Full Text] [Related]
16. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets.
Suzuki-Inoue K; Inoue O; Ding G; Nishimura S; Hokamura K; Eto K; Kashiwagi H; Tomiyama Y; Yatomi Y; Umemura K; Shin Y; Hirashima M; Ozaki Y
J Biol Chem; 2010 Aug; 285(32):24494-507. PubMed ID: 20525685
[TBL] [Abstract][Full Text] [Related]
17. C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice.
Shirai T; Inoue O; Tamura S; Tsukiji N; Sasaki T; Endo H; Satoh K; Osada M; Sato-Uchida H; Fujii H; Ozaki Y; Suzuki-Inoue K
J Thromb Haemost; 2017 Mar; 15(3):513-525. PubMed ID: 28028907
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells.
Suzuki-Inoue K; Kato Y; Inoue O; Kaneko MK; Mishima K; Yatomi Y; Yamazaki Y; Narimatsu H; Ozaki Y
J Biol Chem; 2007 Sep; 282(36):25993-6001. PubMed ID: 17616532
[TBL] [Abstract][Full Text] [Related]
19. Renal cells activate the platelet receptor CLEC-2 through podoplanin.
Christou CM; Pearce AC; Watson AA; Mistry AR; Pollitt AY; Fenton-May AE; Johnson LA; Jackson DG; Watson SP; O'Callaghan CA
Biochem J; 2008 Apr; 411(1):133-40. PubMed ID: 18215137
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of recombinant snake venom rhodocytin: rhodocytin mutant blocks CLEC-2/podoplanin-dependent platelet aggregation and lung metastasis.
Sasaki T; Shirai T; Tsukiji N; Otake S; Tamura S; Ichikawa J; Osada M; Satoh K; Ozaki Y; Suzuki-Inoue K
J Thromb Haemost; 2018 May; 16(5):960-972. PubMed ID: 29488681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
